Sapphire Ventures led a $163m Series D round in SWORD Health, with participation from Sozo Ventures, Willoughby Capital, ADQ, Localglobe, General Catalyst, Khosla Ventures, Founders Fund, Bond, Transformation Capital, and Green Innovations. "SWORD Health’s approach to resolving MSK disorders is truly differentiated. Their unique PT + Digital Therapist model which includes an FDA listed device has gained significant market acceptance evidenced by their 12x customer growth. Through our market and customer work, we found that SWORD is providing tangible clinical outcomes to drive healthier, happier lives for individuals, and meaningful cost-savings for customers – a winning approach. Most of all, we are thrilled to partner with Virgilio, one of the hardest working and passionate founders we’ve encountered," Rajeev Dham, Sapphire Ventures Partner.